Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study
Intestinal Research · 30.04.2023 · 21 (2) · 252-265
DOI: 10.5217/ir.2022.00092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intestinal Research, erschienen am 30.04.2023. Verfasst von Eun Hye Oh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hanyang University Guri Hospital, Guri, Korea. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Society of Gastroenterology.
Abstract (Originalsprache)
Background/Aims: We conducted a nationwide population-based study to investigate incidence rates of colorectal and biliary cancers according to accompanying primary sclerosing cholangitis in Korean ulcerative colitis patients.
Methods
We used the Health Insurance Review and Assessment claim database from January 2007 to April 2020. Standardized incidence ratios of colorectal and biliary cancers in ulcerative colitis patients were calculated.
Results
Among 35,189 newly diagnosed ulcerative colitis patients, 1,224 patients were diagnosed with primary sclerosing cholangitis. During the study period, 122 and 52 patients were diagnosed with colorectal and biliary cancers, respectively. Incidences of colorectal cancer were not higher in ulcerative colitis patients than those in the general population (standardized incidence ratios, 0.83; 95% confidence interval, 0.69–0.99), regardless of accompanied primary sclerosing cholangitis (standardized incidence ratio, 0.73; 95% confidence interval, 0.24–1.71). While incidences of biliary cancer were not higher in ulcerative colitis patients than those in the general population (standardized incidence ratio, 1.14; 95% confidence interval, 0.80–1.58), these were much higher with accompanied primary sclerosing cholangitis (standardized incidence ratio, 10.07; 95% confidence interval, 5.75–16.36). Cumulative incidences of colorectal and biliary cancers increased in patients who were diagnosed with ulcerative colitis at an older age.
Conclusions
In Korean ulcerative colitis patients, colorectal cancer incidences were not higher than those in the general population regardless of accompanied primary sclerosing cholangitis. However, biliary cancer incidences were much higher in ulcerative colitis patients with primary sclerosing cholangitis than in those without, or in the general population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Hanyang University Guri Hospital, Guri, Korea.
- Department of Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Gastroenterology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
- Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Förderung
- Korean Society of Gastroenterology
Zitieren
APA
Oh, E. H., Kim, Y. J., Kim, M., Park, S. H., Kim, T. O., & Park, S. H. (2023). Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study. Intestinal Research, 21(2), 252-265. https://doi.org/10.5217/ir.2022.00092
Vancouver
Oh EH, Kim YJ, Kim M, Park SH, Kim TO, Park SH. Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study. Intestinal Research. 2023;21(2):252-265. doi:10.5217/ir.2022.00092
BibTeX
@article{Oh2023,
author = {Oh, Eun Hye and Kim, Ye-Jee and Kim, Minju and Park, Seung Ha and Kim, Tae Oh and Park, Sang Hyoung},
title = {Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study},
journal = {Intestinal Research},
year = {2023},
volume = {21},
number = {2},
pages = {252--265},
doi = {10.5217/ir.2022.00092}
}
EUVIMED